Carmel-based MBX Biosciences shares jump 48% in Nasdaq debut
Carmel-based MBX Biosciences Inc. saw it shares jump nearly 48% in its debut Friday on the Nasdaq. The five-year-old company is developing treatments for endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity.... Read More
